Abstract
The correlation between hypoxia and pancreatic cancer has long been discussed. Hao’s research team made many efforts on revealing the oncogenic function of hypoxic inducible factor-1 (HIF-1) in pancreatic cancer progression and development in recent years. Based on their research, they linked micro-environmental regulation of pancreatic cancer and its clinical significance. Hao’s research team suggests it is a promising approach to target HIF-1 for the management of pancreatic cancer progression and invasion.
Original language | English (US) |
---|---|
Pages (from-to) | 2029-2031 |
Number of pages | 3 |
Journal | Drug Design, Development and Therapy |
Volume | 9 |
DOIs |
|
State | Published - Apr 8 2015 |
Keywords
- HIF-1
- Hypoxia
- Pancreatic cancer
ASJC Scopus subject areas
- Pharmacology
- Pharmaceutical Science
- Drug Discovery